Senator Shelley Moore Capito (R-West Virginia) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on January 06th, the Senator disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on December 20th.
Senator Shelley Moore Capito also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of General Electric (NYSE:GE) on 12/27/2024.
- Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 12/16/2024.
- Sold $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 12/13/2024.
- Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 12/12/2024.
- Purchased $1,001 – $15,000 in shares of Carlisle Companies (NYSE:CSL) on 10/8/2024.
UnitedHealth Group Trading Up 1.9 %
Shares of UNH opened at $524.14 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a 50-day moving average price of $557.00 and a 200 day moving average price of $561.46. The company has a market capitalization of $482.36 billion, a P/E ratio of 34.15, a P/E/G ratio of 1.53 and a beta of 0.62.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on UNH. Morgan Stanley cut their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. KeyCorp started coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Barclays increased their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $627.58.
Read Our Latest Research Report on UNH
Institutional Trading of UnitedHealth Group
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Hanlon Investment Management Inc. bought a new position in shares of UnitedHealth Group in the second quarter valued at $200,000. Parcion Private Wealth LLC lifted its holdings in shares of UnitedHealth Group by 22.6% during the second quarter. Parcion Private Wealth LLC now owns 1,500 shares of the healthcare conglomerate’s stock valued at $764,000 after purchasing an additional 277 shares during the last quarter. Norden Group LLC increased its stake in UnitedHealth Group by 15.6% in the 2nd quarter. Norden Group LLC now owns 6,080 shares of the healthcare conglomerate’s stock worth $3,097,000 after purchasing an additional 820 shares in the last quarter. Umpqua Bank boosted its holdings in shares of UnitedHealth Group by 3.5% in the second quarter. Umpqua Bank now owns 5,412 shares of the healthcare conglomerate’s stock worth $2,756,000 after buying an additional 184 shares during the period. Finally, Strategic Financial Concepts LLC raised its holdings in shares of UnitedHealth Group by 43,843.0% during the second quarter. Strategic Financial Concepts LLC now owns 232,019 shares of the healthcare conglomerate’s stock valued at $118,158,000 after acquiring an additional 231,491 shares during the period. Institutional investors own 87.86% of the company’s stock.
About Senator Capito
Shelley Moore Capito (Republican Party) is a member of the U.S. Senate from West Virginia. She assumed office on January 3, 2015. Her current term ends on January 3, 2027. Capito (Republican Party) ran for re-election to the U.S. Senate to represent West Virginia. She won in the general election on November 3, 2020. Capito was first elected to the Senate in 2014, becoming the first female U.S. Senator in the state’s history. Prior to serving in the Senate, Capito was a member of the West Virginia House of Representatives from 1997 to 2001 and a member of the United States House of Representatives from 2001 to 2015. At the start of the 116th Congress, Capito was a member of the U.S. Senate committees on Appropriations, Commerce, Science, and Transportation, Environment and Public Works, and Rules and Administration. As of a 2014 analysis of multiple outside rankings, Capito is a more moderate right of center Republican Party vote. As a result, she may break with the Republican Party line more than her fellow members. Capito earned her bachelor’s degree from Duke University. After earning her M.Ed. from the University of Virginia, Capito was a college counselor and then director of an educational information center. She was the only Republican in the West Virginia congressional delegation until the 2010 elections and is the first Republican woman elected to Congress from West Virginia. Capito is a former chairwoman of the Congressional Caucus for Women’s Issues, as well as a member of the Congressional Arts Caucus. After an explosion responsible for the death of 29 coal workers, Capito founded the Congressional Coal Caucus. Prior to her election to the U.S. House, Capito served in the West Virginia House of Delegates.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Smart Picks: Discounted Stocks for Savvy Investors
- Do ETFs Pay Dividends? What You Need to Know
- NVIDIA Deal Ignites Aurora Stock’s Explosive Potential
- How to Invest in Small Cap Stocks
- Why AMD Stock Might Already Be This Year’s Best Buy
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.